[Oxygen pressure and oxygen consumption in coronary venous blood as well as the changes of the arterio-coronary venous O2 content difference and the coronary circulation with high doses of 2,6-(diethanolamino)-4,-8-dipiperidinopyrimido -(5,4-d) pyrimidine (Persantin)].
D000328:Adult; D000368:Aged; D001783:Blood Flow Velocity; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption / Q000187:drug effects*; D011674:Pulse / Q000187:drug effects
D004176:Dipyridamole; D010100:Oxygen
Sauerstoffdruck und Sauerstoffsättigung im koronarvenösen Blut sowie die Veränderungen der arterio-koronarvenösen O2-Gehalt-Differenz und des Koronardurchflusses unter hohen Dosen von 2,6-(diaethanolamino) -4,-8-dipiperidino-pyrimido (5,4-d) pyrimidin (Persantin)